Table: begin end state 1 35 cytoplasmic 36 52 transmembrane 53 59 non-cytoplasmic 60 82 transmembrane 83 93 cytoplasmic 94 114 transmembrane 115 119 non-cytoplasmic 120 145 transmembrane 146 158 cytoplasmic 159 183 transmembrane 184 193 non-cytoplasmic 194 213 transmembrane 214 244 cytoplasmic 245 265 transmembrane 266 283 non-cytoplasmic 284 305 transmembrane 306 313 cytoplasmic 314 333 transmembrane 334 338 non-cytoplasmic 339 361 transmembrane 362 376 cytoplasmic 377 395 transmembrane 396 405 non-cytoplasmic 406 425 transmembrane 426 437 cytoplasmic
Input: >GFF4482 FitnessBrowser__WCS417:GFF4482 MSTTYNEAAPAAAPTNSTARVATASIVGTAIEFYDFYIYATAAALVIGPVFFPQTSGTAQ MLASFLTFGIAFIARPLGSALFGHFGDRIGRKSTLVASLLLMGVCTTLIGLLPGYDSIGA WAPILLCVLRFGQGLGLGGEWGGAALLATENAPKGKRAWFGMFPQLGPSIGFLAANGLFL ILAMSLSDEQFRSWGWRIPFILSAALVMVGLYARLKLHETPVFANAVAKEAPVKVPLVEL FSQHWLPVLLGAASMVVCYALFYITTAFSLSYGVSTLGYSRETFLGLLCFAVLFMGLATP LAALASDRFGRKPVLIVGALLAILSGFTMEPLLTHGSTWAVALFLALELFLMGVTFAPMG AMLPELFPTRVRYTGASAAYNLGGIVGASAAPFFATKLVAMGGLSYVGGYVSAAALLSLI AVLCLKETRDNDLNKVA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server